Profiel
Thomas A. Keuer is currently the President & Chief Executive Officer at ARCA biopharma, Inc. He previously held the position of Vice President-Engineering at Baxter Healthcare Corp.
and Baxter International, Inc. He also served as Vice President-Operations at Somatogen, Inc. and as Senior Vice President-Operations at Insmed, Inc. Additionally, he was the Executive Vice President-Pharmaceutical Operations at ARCA biopharma, Inc. Mr. Keuer graduated from Rice University with a graduate degree and from The University of Texas at Austin with an undergraduate degree.
Eerdere bekende functies van Thomas Keuer
| Bedrijven | Functie | Einde |
|---|---|---|
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Operationeel Directeur | 29-01-2009 |
| INSMED INCORPORATED | Operationeel Directeur | 01-11-2006 |
| BAXTER INTERNATIONAL INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2004 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Corporate Officer/Principal | 01-01-2004 |
| ARCA BIOPHARMA | Algemeen Directeur | - |
Opleiding van Thomas Keuer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Somatogen, Inc.
Somatogen, Inc. BiotechnologyHealth Technology Develops specialty oxygen therapeutics | Health Technology |
Insmed, Inc.
Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
Rice University
Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARCA biopharma, Inc.
ARCA biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
















